Circulating Proteins as Predictors of Improvement in Physical Function in Hospitalized Older Adults with Geriatric Syndromes: Findings from the REHAB-HF Trial

When an older adult is hospitalized for heart failure, the immediate crisis is often just the beginning of a longer struggle. The heart's inability to pump blood effectively can lead to a cascade of other problems, including a loss of muscle strength, poor balance, and a general decline in the ability to move around the house or community. These overlapping challenges are known as geriatric syndromes, and they often determine whether a patient can return to a normal life or remains frail and dependent. For decades, doctors have relied on broad clinical scores to guess how well a patient might recover, but these tools often miss the unique biological makeup of the individual. In recent years, scientists have turned their attention to the blood itself, looking for specific proteins that act as messengers, signaling inflammation or stress within the body. The hope has been that these tiny molecules could reveal not just how sick a person is, but how their body might respond to a specific treatment, such as a carefully designed exercise program.

A team of researchers set out to test this idea in a large group of older adults who had recently been admitted to the hospital for heart failure. They wanted to know if measuring the levels of ninety-two different proteins in a patient's blood before they started treatment could predict who would benefit most from a twelve-week rehabilitation program. This program was not a generic gym routine; it was a tailored, progressive regimen led by physical therapists that included aerobic exercise, strength training, balance work, and flexibility drills. The study compared these participants to a control group that received standard attention but not the specialized exercise plan. The goal was to see if the blood markers could act as a guide, helping doctors identify which patients were likely to see significant improvements in their physical function, such as the ability to walk longer distances or perform daily tasks like rising from a chair.

The researchers analyzed blood samples from nearly two hundred and forty participants, measuring the levels of proteins known to be linked with heart disease and inflammation. They then tracked how much each person's physical performance improved over the course of the twelve weeks. By using advanced statistical methods to sift through the data, the team discovered that specific combinations of proteins could indeed separate those who responded well to the exercise from those who did not. For the ability to perform physical tasks, the levels of two proteins, identified as GP6 and ST2, were key. The researchers built a decision model that showed a specific profile of ST2 followed by GP6 levels identified a group likely to see a substantial improvement in their physical scores after the program. In contrast, those who did not fit this profile saw a differential change of -0.8 points compared to the control group, whereas the matched group saw an improvement of 2.1 points.

Similarly, when looking at how far participants could walk in six minutes, the researchers found that a single protein called ALCAM was the strongest predictor. Patients with certain levels of this protein in their blood saw their walking distance increase by an average of eighty-five meters after the twelve-week program, a significant gain that the control group did not achieve. Those without this specific protein profile saw a much smaller change, essentially showing no real difference from the group that did not exercise. These findings suggest that the blood contains a biological signature that can forecast who will thrive with rehabilitation and who might need a different approach.

However, the study also clarified what these proteins are not. While they were excellent at predicting who would improve, the researchers found no evidence that these proteins were the actual cause of the improvement. In other words, the proteins did not act as the mechanism that made the muscles stronger or the heart work better; they were simply markers that signaled a body ready to respond. The study did not prove that changing the levels of these proteins would change the outcome, nor did it suggest that the proteins themselves were the target of the therapy. Instead, they serve as a sort of biological map, pointing toward patients who are likely to get the most out of a structured exercise plan. The work confirms that while exercise is powerful, its benefits are not uniform for everyone, and understanding the individual's protein profile could help tailor care to ensure that the right patients receive the right intensity of rehabilitation.